Endocannabinoid system and epigenetics in spermatogenesis and testicular cancer.


Journal

Vitamins and hormones
ISSN: 0083-6729
Titre abrégé: Vitam Horm
Pays: United States
ID NLM: 0413601

Informations de publication

Date de publication:
2023
Historique:
entrez: 2 3 2023
pubmed: 3 3 2023
medline: 7 3 2023
Statut: ppublish

Résumé

In mammals, male germ cell development starts during fetal life and is carried out in postnatal life with the formation of sperms. Spermatogenesis is the complex and highly orderly process during which a group of germ stem cells is set at birth, starts to differentiate at puberty. It proceeds through several stages: proliferation, differentiation, and morphogenesis and it is strictly regulated by a complex network of hormonal, autocrine and paracrine factors and it is associated with a unique epigenetic program. Altered epigenetic mechanisms or inability to respond to these factors can impair the correct process of germ development leading to reproductive disorders and/or testicular germ cell cancer. Among factors regulating spermatogenesis an emerging role is played by the endocannabinoid system (ECS). ECS is a complex system comprising endogenous cannabinoids (eCBs), their synthetic and degrading enzymes, and cannabinoid receptors. Mammalian male germ cells have a complete and active ECS which is modulated during spermatogenesis and that crucially regulates processes such as germ cell differentiation and sperm functions. Recently, cannabinoid receptor signaling has been reported to induce epigenetic modifications such as DNA methylation, histone modifications and miRNA expression. Epigenetic modifications may also affect the expression and function of ECS elements, highlighting the establishment of a complex mutual interaction. Here, we describe the developmental origin and differentiation of male germ cells and testicular germ cell tumors (TGCTs) focusing on the interplay between ECS and epigenetic mechanisms involved in these processes.

Identifiants

pubmed: 36863802
pii: S0083-6729(23)00002-X
doi: 10.1016/bs.vh.2023.01.002
pii:
doi:

Substances chimiques

Endocannabinoids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-106

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Marco Barchi (M)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Eugenia Guida (E)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Susanna Dolci (S)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Pellegrino Rossi (P)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Paola Grimaldi (P)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electronic address: p.grimaldi@med.uniroma2.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH